in Newswire Published on December 11, 2018

Class Action Alleges Mylan, Rite Aid Continued to Sell Contaminated High Blood Pressure Drug Despite Sweeping Recalls

Cacaccio v. Mylan Pharmaceuticals, Inc. et al.

Filed: December 5, 2018 § 2:18-cv-06916

Mylan and Rite Aid are facing a class action that claims the companies respectively manufactured and sold generic valsartan medications despite possessing knowledge that the drugs were contaminated with probable carcinogen N-nitrosodiethylamine (NDEA).

Law(s)

State(s)

New York

Categories

Medical/Health Fraud

Case Spotlight

Hair Relaxer Lawsuits

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on December 11, 2018 — 4:40 PM

Erin Shaak

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.